These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2457789)

  • 1. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
    Manganiello V; Degerman E; Elks M
    Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for soluble cAMP phosphodiesterases in differentiation of 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    J Cell Physiol; 1985 Aug; 124(2):191-8. PubMed ID: 2413050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
    Glass WF; Moore JB
    Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cyclic AMP phosphodiesterase isozymes in rat parotid gland.
    Imai A; Nashida T; Shimomura H
    Arch Oral Biol; 1995 Feb; 40(2):165-8. PubMed ID: 7794130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey.
    Bocek RM; Beatty CH
    Dev Biol; 1976 Feb; 48(2):382-91. PubMed ID: 176071
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioprotection of mouse intestine by inhibitors of cyclic AMP phosphodiesterase.
    Lehnert S
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):825-33. PubMed ID: 91600
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective inhibition of two soluble adenosine cyclic 3',5'-phosphate phosphodiesterases partially purified from calf liver.
    Yamamoto T; Lieberman F; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
    Biochemistry; 1984 Feb; 23(4):670-5. PubMed ID: 6324851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle.
    Endoh M; Satoh K; Yamashita S
    Eur J Pharmacol; 1980 Aug; 66(1):43-52. PubMed ID: 6157546
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
    Shechter Y
    Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors.
    Palmer D; Tsoi K; Maurice DH
    Circ Res; 1998 May; 82(8):852-61. PubMed ID: 9576105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
    Shimizu E; Kobayashi Y; Oki Y; Kawasaki T; Yoshimi T; Nakamura H
    Life Sci; 1999; 64(23):2081-8. PubMed ID: 10372650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones.
    Goff AK; Major PW
    FEBS Lett; 1976 Jan; 61(2):144-7. PubMed ID: 174943
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of bone loss by denbufylline, an inhibitor of phosphodiesterase 4.
    Miyamoto K; Waki Y; Horita T; Kasugai S; Ohya K
    Biochem Pharmacol; 1997 Sep; 54(5):613-7. PubMed ID: 9337078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences and similarities between guanosine 3',5'-cyclic monophosphate phosphodiesterase and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in neuroblastoma cells in culture.
    Prasad KN; Becker G; Tripathy K
    Proc Soc Exp Biol Med; 1975 Jul; 149(3):757-62. PubMed ID: 167381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism.
    Zhu WH; Majluf-Cruz A; Omburo GA
    Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
    Schwabe U; Miyake M; Ohga Y; Daly JW
    Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical stimulation by 1-methyl-3-isobutylxanthine of rat liver cyclic AMP phosphodiesterase activity.
    Erneux C; Miot F; Boeynaems JM; Dumont JE
    FEBS Lett; 1982 Jun; 142(2):251-4. PubMed ID: 6179796
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormonal regulation of adipocyte particulate "low Km" cAMP phosphodiesterase.
    Manganiello VC; Smith CJ; Newman AH; Rice K; Degerman E; Belfrage P
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):497-511. PubMed ID: 2450112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.